UDCA (Ursodeoxycholic acid): Research, Dosing, and Where to Buy in 2026
A research-first profile for UDCA (Ursodeoxycholic acid) (ursodeoxycholic acid), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
UDCA (Ursodeoxycholic acid) is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers for UDCA (Ursodeoxycholic acid), each linked to its source.
- Also indexed as ursodeoxycholic acid.
- 0 aggregated dosing-protocol mentions from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is UDCA (Ursodeoxycholic acid)?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
UDCA (Ursodeoxycholic acid) Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
No transcript-derived dosing mentions in current source set.
Where to Buy UDCA (Ursodeoxycholic acid) in 2026
No tracked vendor recommendations for UDCA (Ursodeoxycholic acid) yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about UDCA (Ursodeoxycholic acid). Each line links to the original source.
- "During the follow-up period, the probability of ALP normalization was significantly higher in the fibrate/UDCA group (hazard ratio [HR] = 5.00, 95% confidence interval = 2.87-8.27, P < 0.001)." · Chung S et al, 2019 PubMed
- "Among 58 non-cirrhotic patients (43 in the UDCA group and 15 in the fibrate/UDCA group), 19 patients (44.1%) in the UDCA group and none in the fibrate/UDCA group developed cirrhosis (HR = 0.12, P = 0.04)." · Chung S et al, 2019 PubMed
- "Hepatic deterioration (Child-Pugh score increase or signs of decompensated cirrhosis) occurred in 17 patients (23.9%) of the UDCA group and none in the fibrate/UDCA group in which the difference was significant (HR = 0.12, P = 0.04)." · Chung S et al, 2019 PubMed
- "The now available chemical routes for the obtainment of UDCA yield about 30% of final product." · Tonin F et al, 2018 PubMed
- "Pruritus resolved in 40% of the patients of UDCA group vs 19% in placebo group." · Calmus Y et al, 1991 PubMed
Research and Studies
8 PubMed-indexed papers reference UDCA (Ursodeoxycholic acid). Top 8 shown.
Legal Status
UDCA (Ursodeoxycholic acid) is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is UDCA (Ursodeoxycholic acid) FDA-approved?
UDCA (Ursodeoxycholic acid) is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
How much research has been published on UDCA (Ursodeoxycholic acid)?
8 PubMed-indexed paper(s) reference UDCA (Ursodeoxycholic acid) in our current research feed. See the Research and Studies section above for citations.